Pixalate's May 2025 US Publisher Rankings: Top Mobile Gaming Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store
According to Pixalate's May 2025 rankings, 'X2 Blocks® - 2048 Number Game' is No. 1 on the Google App Store, and 'Pyramid Solitaire' is No. 1 on the Apple App Store based on programmatic advertising traffic quality in the United States (U.S.)
London, June 02, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading global platform for ad fraud protection, privacy, and compliance analytics, today released the U.S. May 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic Quality on the Apple App Store and the Google Play Store.
The report ranks mobile apps in the 'Video Gaming' IAB app category based on their programmatic advertising traffic quality, as measured by Pixalate's Publisher Trust Index (PTI). Pixalate has also released a United Kingdom (U.K.) version of the report.
The Pixalate Publisher Trust Index is published monthly, highlighting the top apps based on Pixalate's proprietary technology and methodology.
US Mobile PTI Rankings: Top 'Gaming' Apps (May 2025)
Apple App Store
Pyramid Solitaire
Jigsaw Puzzle
8 Ball Pool™
Google Play Store
X2 Blocks® - 2048 Number Game
Bubbu – My Virtual Pet Cat
Solitaire Classic Card Game
Download the full rankings here.
Pixalate uses its proprietary algorithms to measure quality metrics, including invalid traffic (IVT, including ad fraud), Made For Advertising (MFA) risk, brand safety, ad density, viewability, reach, and other metrics. The Publisher Trust Indexes include rankings for over 235 countries across four global regions ( North America, EMEA, APAC, and LATAM). They also provide breakdowns by 20+ different IAB taxonomy website categories. Pixalate's methodology can be found at Publisher Trust Index: Methodology.
Pixalate's data science team analyzed over 15 billion global open programmatic ad impressions across over 600k Google Play Store and Apple App Store mobile apps in the 'Video Gaming' IAB category in May 2025 to compile this report.
Download the Reports
US Publisher Trust Index - Top Games
UK Publisher Trust Index - Top Games
About Pixalate
Pixalate is a global platform specializing in privacy compliance, ad fraud prevention, and digital ad supply chain data intelligence. Founded in 2012, Pixalate is trusted by regulators, data researchers, advertisers, publishers, ad tech platforms, and financial analysts across the Connected TV (CTV), mobile app, and website ecosystems. Pixalate is accredited by the MRC for the detection and filtration of Sophisticated Invalid Traffic (SIVT). pixalate.comThe Publisher Trust Index (PTI) reflects Pixalate's opinions with respect to factors that Pixalate believes may be useful to the digital media industry. Our reports and indexes examine programmatic advertising activity on mobile apps and Connected TV (CTV) apps. Any insights shared are grounded in Pixalate's proprietary technology and analytics, which Pixalate is continuously evaluating and updating. Any references to outside sources in the Indexes and herein should not be construed as endorsements. Pixalate's opinions are just that, opinions, which means that they are neither facts nor guarantees. This report is not intended to impugn the standing or reputation of any person, entity or app. Per the MRC, ''Fraud' is not intended to represent fraud as defined in various laws, statutes and ordinances or as conventionally used in U.S. Court or other legal proceedings, but rather a custom definition strictly for advertising measurement purposes. Also per the MRC, ''Invalid Traffic' is defined generally as traffic that does not meet certain ad serving quality or completeness criteria, or otherwise does not represent legitimate ad traffic that should be included in measurement counts. Among the reasons why ad traffic may be deemed invalid is it is a result of non-human traffic (spiders, bots, etc.), or activity designed to produce fraudulent traffic.'
CONTACT: Nina Talcott ntalcott@pixalate.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Telix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer Detection
Telix Pharmaceuticals recently gained marketing authorization for its prostate cancer imaging agent, Illuccix®, in Portugal. This development enhances diagnostic options in a country where prostate cancer is prevalently diagnosed. Last week, the company's share price rose by 3%, a move that aligns with its recent regulatory success. Although the broader market remained steady over the same period, Telix's approval could provide additional support to its stock performance. The growth in Telix's share price complements the longer-term market trend, with broader market earnings expected to grow annually, positioning the company favorably. We've discovered 1 risk for Telix Pharmaceuticals that you should be aware of before investing here. We've found 20 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Over the past five years, Telix Pharmaceuticals has delivered a tremendous total shareholder return of 1863.90%. In the past year, Telix's performance surpassed the Australian Biotechs industry, which saw a 10.2% decline, highlighting the company's robust and resilient market position. The recent marketing authorization for Illuccix® in Portugal is expected to bolster revenue streams, complementing the company's efforts to expand its presence across international markets. These developments align with revenue forecasts expecting annual growth of 19.5%, outpacing the broader Australian market's expected growth of 5.6% annually. Telix's earnings forecasts also suggest promising growth, projected to rise significantly at 33.2% per year, compared to the market's 11.7%. This is supported by the company's strategic approvals and existing product portfolio, contributing to upward earnings revisions. The current share price movement, slightly below the consensus analysts' price target of A$32.05, suggests that there may be potential for further share price appreciation as the company continues to execute its growth strategy. The recent developments reinforce investor confidence in Telix's ability to sustain its growth trajectory in a competitive industry landscape. Gain insights into Telix Pharmaceuticals' past trends and performance with our report on the company's historical track record. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:TLX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
29 minutes ago
- Yahoo
New Wearable Tech Tracks Astronauts' Sleep Quality on International Space Station
ISS National Lab-sponsored research on Axiom Mission 4 tests wearable tech to collect, analyze sleep data and readiness for critical tasks KENNEDY SPACE CENTER, Fla., June 4, 2025 /PRNewswire/ -- Everyone needs a good night's sleep to perform at their best—including astronauts. A technology demonstration launching to the International Space Station (ISS) on Axiom Mission 4 (Ax-4) will test a wearable device that collects biometric data such as total sleep time and heart rate variability during sleep. The project, sponsored by the ISS National Laboratory®, is a collaborative effort between Booz Allen, Axiom Space, and Oura. The demonstration aims to utilize edge computing to process and analyze biometric data in near real time, enabling crew members to make informed decisions about whether they are prepared for critical tasks. "This technology will provide crew members with detailed insights into their sleep quality and biometrics, which will help them to understand how this directly impacts their fitness and ability to best execute their duties the next day," said Josh Arceneaux, director of human space flight at Booz Allen. If successful, the demonstration would highlight the potential to eliminate the need for ground communication for certain activities, allowing crew members to operate more autonomously. This capability will be increasingly vital for future long-duration missions, such as those to Mars, where communication delays and other challenges will become more prevalent. As with many commercial devices that track data on personal physical condition and performance, the information collected by each Oura Ring is sent to the company's corporate cloud for analysis and storage and then provided to the user via a smartphone app. In orbit, the data will be processed by an edge computing device and provided directly to the crew member for evaluation. "Ultimately, this demonstration will showcase whether we can collect, store, and analyze that data and empower crew members to make decisions without needing to connect to the ground," Arceneaux said. "This is part of a bigger objective to move abilities we're accustomed to having on the ground to use in spaceflight." Ax-4 is scheduled to launch no earlier than June 10, 2025, at 8:22 a.m. EDT, from Florida. For additional information on ISS National Lab-sponsored investigations launching on Ax-4, visit our launch page. To learn more about the research and technology development sponsored by the ISS National Lab, visit our website. Download a high-resolution image for this release: Astronauts Test Wearable Tech About the International Space Station (ISS) National Laboratory:The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Space® (CASIS®) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website. As a 501(c)(3) nonprofit organization, CASIS accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page. Media Contact: Patrick O'Neill 904-806-0035PONeill@ International Space Station (ISS) National LaboratoryManaged by the Center for the Advancement of Science in Space® (CASIS®) 1005 Viera Blvd., Suite 101, Rockledge, FL 32955 • 321.253.5101 • View original content to download multimedia: SOURCE International Space Station National Lab Sign in to access your portfolio
Yahoo
32 minutes ago
- Yahoo
Rebel Wilson Shares Wife Ramona Agruma's Reaction to Learning Actress Had a Baby on the Way 3 Months After They Started Dating
Rebel Wilson is looking back on how she told her now wife about her surrogacy journey. On the latest episode of Let's Talk Off Camera with Kelly Ripa, the Pitch Perfect alum, 45, told host Kelly Ripa that she planned to have a baby before meeting her now-wife Ramona Agruma. Wilson, who is the mother of daughter Royce, 2, admitted she had to tell Arguma very early into their relationship that her surrogate was expecting and shared Agruma's reaction to the news. "I'd already been planning to have a baby and I'd had an an embryo and was already planning to have a baby by a surrogate. So very, very, very early in dating, like three months into dating Ramona, I had to tell her, so I have a surrogate and it turns out the surrogate's pregnant," she recalled, noting it was a "huge thing" to say so early into a relationship. "Ramona just turned to me, was sitting at my kitchen table and she said, 'I love you and I'm gonna love your child just as much,' " she continued. "I was so shocked. It's like she didn't even think about it. She just went, 'Oh, that's amazing news.'" is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! The How to Be Single actress told Ripa that her wife, whom she tied the knot with in September 2024, has been the "best mother" to her little one. "She has been the best mother," Wilson said, referring to her wife. "She's way better than me. She's the most kind, caring, nurturing, and I was so lucky," The proud mom also shared that she thinks her relationship with Agruma was "kind of fate," saying that she couldn't have imagined welcoming her child any other way. "At one point, she wasn't gonna be in the delivery room and then the surrogate's like, 'No, bring her in. I want her there,' " she continued. "She was there with me at the very first second when Royce slid out of the surrogate, and we were both there holding our little hands, and I couldn't imagine it any other way now. It was kind of fate." is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! In an interview with PEOPLE for a March 2024 cover story, the comedian and author of Rebel Rising: A Memoir shared one of the things she wasn't prepared for after she welcomed her daughter Royce. "The surprising thing is that you never just walk out of the house and not have plans," Wilson told PEOPLE. "You can't just go, 'I feel like going to the movie cinema,' and just walk out of the house. No, no, no." "You have to plan what's happening with the baby," she continued. "Is the baby coming with you? Have the baby's meals been prepped? You've got to communicate about the baby's schedule, when her nap time is, all the things." Read the original article on People
